DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Morris VK, Salem ME, Nimeiri H. et al.
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): A multicentre, single-arm, phase 2 study.
Lancet Oncol 2017;
18: 446-453
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.